LPA and liver disorder: This study emphasizes the CV, diabetes, and liver disease risks in A-T patients evidenced by atherogenic lipid profile [higher values of Lp(a) and ApoB/Apo A-I], IR, and presence of hepatic steatosis in 64.7% of the patients.